Rexahn Pharmaceuticals, Inc. (RNN) Reports Fourth Quarter And Full-Year 2013 Financial Results And Recent Highlights
3/24/2014 9:34:24 AM
ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and financial results for the year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by